(Q36616067)

English

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17).

scientific article published on June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17). (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

Sophie D. Fosså

2

object named as

S D Fossa

1 reference

Europe PubMed Central

15 August 2017

author name string

D P Dearnaley

1

1 reference

Europe PubMed Central

15 August 2017

S B Kaye

3

1 reference

Europe PubMed Central

15 August 2017

M H Cullen

4

1 reference

Europe PubMed Central

15 August 2017

S J Harland

5

1 reference

Europe PubMed Central

15 August 2017

M P J Sokal

6

1 reference

Europe PubMed Central

15 August 2017

J D Graham

7

1 reference

Europe PubMed Central

15 August 2017

J T Roberts

8

1 reference

Europe PubMed Central

15 August 2017

G M Mead

9

1 reference

Europe PubMed Central

15 August 2017

M V Williams

10

1 reference

Europe PubMed Central

15 August 2017

P A Cook

11

1 reference

Europe PubMed Central

15 August 2017

S P Stenning

12

1 reference

Europe PubMed Central

15 August 2017

MRC Testicular Tumour Working Party

13

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

92

1 reference

Europe PubMed Central

15 August 2017

2107-2113

1 reference

Europe PubMed Central

15 August 2017

12

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602624

0 references

Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

30 September 2017

Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

30 September 2017

Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

30 September 2017

Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

30 September 2017

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

30 September 2017

Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

28 June 2018

BOP/VIP - A new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

28 June 2018

Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

20 September 2018

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361823

20 September 2018

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602624

21 January 2018

Further advances in the management of malignant teratomas of the testis and other sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vincristine, cisplatin, and bleomycin with surgery in the management of advanced metastatic nonseminomatous testis tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy for stage I non-seminomatous testicular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15928672

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6602624

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36616067&oldid=1694337180"